Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Brossi

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|November 16, 2001
Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory actionQ Yu, H W Holloway, J L Flippen-Anderson, et al.
Journal of Medicinal Chemistry|July 1, 1975
Ellipticine derivativesR W Guthrie, A Brossi, F A Mennona, et al.
Journal of Medicinal Chemistry|January 1, 1990
Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolinesM E Bembenek, C W Abell, L A Chrisey, et al.
Neuroscience Letters|September 14, 1992
The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-mazeS Iijima, N H Greig, P Garofalo, et al.
Advances in Neurology|January 1, 1974
L-DOPA: chemical modifications and biological evaluationA Brossi, W Pool, H Sheppard, et al.
Synapse (New York, N.Y.)|January 1, 1988
Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylationM Kawabuchi, A F Boyne, S S Deshpande, et al.
Journal of Neural Transmission|January 1, 1988
Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+C J Sun, J N Johannessen, W Gessner, et al.
Psychopharmacology|January 1, 1993
Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-mazeS Iijima, N H Greig, P Garofalo, et al.
Journal of Medicinal Chemistry|October 1, 1983
Biological effects of modified colchicines. 2. Evaluation of catecholic colchicines, colchifolines, colchicide, and novel N-acyl- and N-aroyldeacetylcolchicinesA Brossi, P N Sharma, L Atwell, et al.
Journal of Medicinal Chemistry|January 29, 2000
Antitumor agents. 199. Three-dimensional quantitative structure-activity relationship study of the colchicine binding site ligands using comparative molecular field analysisS X Zhang, J Feng, S C Kuo, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|November 16, 2001
Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory actionQ Yu, H W Holloway, J L Flippen-Anderson, et al.
Journal of Medicinal Chemistry|July 1, 1975
Ellipticine derivativesR W Guthrie, A Brossi, F A Mennona, et al.
Journal of Medicinal Chemistry|January 1, 1990
Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolinesM E Bembenek, C W Abell, L A Chrisey, et al.
Neuroscience Letters|September 14, 1992
The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-mazeS Iijima, N H Greig, P Garofalo, et al.
Advances in Neurology|January 1, 1974
L-DOPA: chemical modifications and biological evaluationA Brossi, W Pool, H Sheppard, et al.
Synapse (New York, N.Y.)|January 1, 1988
Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylationM Kawabuchi, A F Boyne, S S Deshpande, et al.
Journal of Neural Transmission|January 1, 1988
Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+C J Sun, J N Johannessen, W Gessner, et al.
Psychopharmacology|January 1, 1993
Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-mazeS Iijima, N H Greig, P Garofalo, et al.
Journal of Medicinal Chemistry|October 1, 1983
Biological effects of modified colchicines. 2. Evaluation of catecholic colchicines, colchifolines, colchicide, and novel N-acyl- and N-aroyldeacetylcolchicinesA Brossi, P N Sharma, L Atwell, et al.
Journal of Medicinal Chemistry|January 29, 2000
Antitumor agents. 199. Three-dimensional quantitative structure-activity relationship study of the colchicine binding site ligands using comparative molecular field analysisS X Zhang, J Feng, S C Kuo, et al.
Pageof 12